ARE YOU OPTED IN?
Did you know you can earn rewards while you shop? Once you are signed-up to our CannaRewards Account you will be able to earn points for every purchase you make. Rewards can then be converted into discounts to use on your future orders.
You can sign up by clicking the rewards bubble floating on the right-hand side of all pages on the website.
- 5 CannaPoints for every £1 spent
- Signup get 100 CannaPoints
- Like on Facebook get 50 CannaPoints
- Follow on Instagram get 50 CannaPoints
- Refer a friend and you will BOTH receive a £5 voucher
Fresh From The Blog
Keep up to date with the latest news in the Cannabis Industry!
ADHD stands for Attention-Deficit/Hyperactivity Disorder and is one of the most prominent mental health disorders that affect children and young adults. That said, it is not just limited to young, as many adults are also affected by ADHD.
As CBD has increased in popularity globally, many people are looking to see if it may be able to help with their particular ailment or condition. One of the conditions that CBD may be useful in treating is Parkinson’s disease, although more research still needs to be done.
Millions of people around the world have to live with psoriasis as part of their daily lives. Psoriasis is an auto-immune disease, and it is chronic in its nature. Those who suffer with psoriasis often have an overactive immune system which causes skin cells to grow faster than they should. This results in the skin becoming red, scaly and extremely painful patches of skin begin to build up. The areas of skin that are impacted by psoriasis are itchy, disruptive and quite unseemly.
Within the burgeoning UK cannabis industry there is a tremendous need to build both clinical and real-world evidence to support the efficacy of cannabinoid treatments. Existing cannabis-based medications offer little intellectual property protection due to the difficulty of patenting a specific indication of cannabis. The device used to administer the active pharmaceutical ingredient (API) is the only protection cannabis and pharmaceutical companies can have. Therefore, undertaking a clinical trial with a medication that cannot be patented and can be easily copied, does not make for an attractive proposition for companies in the cannabis space.